Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility

Keyphrases

• Next-generation Sequencing 100%
• Small Bowel Adenocarcinoma 100%
• Molecular Pathology 100%
• DNA Methylation Profiling 100%
• Pathological Analysis 100%
• Tumor 50%
• Clinical Application 50%
• High-throughput 50%
• Array Data 50%
• CDH1 50%
• CpG Methylation 50%
• Gene Expression Array 50%
• Cancer Cases 50%
• RNA Transcripts 50%
• Spearman 50%
• ErbB4 50%
• Notch1 50%
• Small Intestine 50%
• Novel mutation 50%
• Nucleophosmin 1 (NPM1) 50%
• Molecular Profiling 50%
• Poor Survival 50%
• Molecular Profile 50%
• FMS-like Tyrosine Kinase 3 (FLT3) 50%
• Hypomethylation 50%
• Patient Matched 50%
• Isocitrate Dehydrogenase 1 (IDH1) 50%
• Tumor Protein p53 (TP53) 50%
• CHN2 50%
• Fibroblast Growth Factor Receptor 2 (FGFR2) 50%
• Incidence Rate 50%
• Adenocarcinoma 50%
• Hypermethylated 50%
• Methylation Array 50%
• AKT1 50%

Biochemistry, Genetics and Molecular Biology

• Gene Expression 100%
• DNA Methylation 66%
• Next Generation Sequencing 66%
• Methylation 33%
• RNA 33%
• AKT1 33%
• NPM1 33%
• IDH1 33%
• ERBB4 33%
• Fibroblast Growth Factor Receptor 2 33%